Ironshore Pharmaceuticals Inc.
5 drugs in NADAC|0 Generic,5 Brand
Ironshore Pharmaceuticals Inc. lists 5 NDCs in the CMS NADAC file (0 generic, 5 brand), at an average NADAC of $15.40 per unit, with a week-over-week move of -0.0% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
5
0G / 5B
Avg Price / Unit
$15.3995
$15.39 – $15.41
Avg 7d Change
-0.01%
Across 4 drugs with changes
7d Activity
of 5 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Lead market
Methylphenidate Hydrochloride market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Lead class
Central Nervous System Stimulant therapeutic class
Review the broader class where Ironshore Pharmaceuticals Inc. has the strongest current portfolio footprint.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does Ironshore Pharmaceuticals Inc. make?
Ironshore Pharmaceuticals Inc. lists 5 NDCs in the CMS NADAC file — 0 generic and 5 brand products.
What is the average price of Ironshore Pharmaceuticals Inc. drugs?
The average NADAC across Ironshore Pharmaceuticals Inc.'s portfolio is $15.3995 per unit, ranging from $15.3930 to $15.4051.
What types of drugs does Ironshore Pharmaceuticals Inc. make?
Ironshore Pharmaceuticals Inc. makes drugs across 1 FDA pharmacologic class. The most common by NDC count are Central Nervous System Stimulant (5).
Has Ironshore Pharmaceuticals Inc. had any drug recalls?
No FDA enforcement recalls are matched to Ironshore Pharmaceuticals Inc. in the openFDA feed.
How has Ironshore Pharmaceuticals Inc.'s pricing changed recently?
Over the past 7 days, 1 Ironshore Pharmaceuticals Inc. product rose and 3 fell, with a portfolio-wide average change of -0.0%.
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
JORNAY PM 40 MG CAPSULE Methylphenidate Hydrochloride | $15.4051 per EA | -0.02% |
JORNAY PM 60 MG CAPSULE Methylphenidate Hydrochloride | $15.4019 per EA | -0.02% |
JORNAY PM 80 MG CAPSULE Methylphenidate Hydrochloride | $15.4015 per EA | 0.00% |
JORNAY PM 100 MG CAPSULE Methylphenidate Hydrochloride | $15.3960 per EA | +0.02% |
JORNAY PM 20 MG CAPSULE Methylphenidate Hydrochloride | $15.3930 per EA | -0.02% |